Delivery Order SPE2DR25D3018-SPE2DR26FR8UJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 3, 2025. This firm fixed-price contract, awarded on September 2, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Valtoco is a naloxone nasal spray formulation used for...
- The Defense Logistics Agency awarded a $2,208.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 20 mg nasal sprays. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a discrete transaction under the company's broader federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays under a firm fixed-price contract with a ceiling value of $1,126.10. The order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its Corporate Office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,385.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with an ultimate completion date of August 15, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order contains no set-aside...
- The Defense Logistics Agency awarded a $2,185.16 delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on November 3, 2025, with completion scheduled for November 4, 2025. This is a firm fixed-price contract with no set-aside designation, awarded competitively under an existing indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, valued at $2,839.00, with an ultimate completion date of September 10, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Valtoco 5 mg nasal spray, with a ceiling value of $2,252.20 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency awarded a $1,129.62 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with completion scheduled for November 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a $4,938.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The pharmaceutical will be delivered to the contractor's location in Conshohocken, Pennsylvania, supporting federal medical...
- SPE2DR25D3018Indefinite Delivery Contract
- SPE2DR25D3018-SPE2DR26FR8UJDelivery Order
The Defense Logistics Agency awarded a $2,415.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with performance in Conshohocken, Pennsylvania and completion scheduled for December 12, 2025. This delivery order represents a non-set-aside, competitively awarded contract and is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. Valtoco is a naloxone nasal spray formulation used for emergency reversal of opioid overdose, supporting critical medical supply needs for military healthcare systems and related federal agencies. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contracts with DLA covering a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. The company's SPE2DX master contract enables flexible fulfillment of pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with DLA Troop Support planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple regional awards across different contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/10/25 |